MassDevice.com +5 | The top 5 medtech stories for April 17, 2017

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Star Trek tricorder: This may be the best we can do – for now They don’t diagnose diseases with a few waves of the hand, the way that Dr. Leonard McCoy would with his tricorder on Star Trek. But 2 mobile platforms – algorithms and sensors paired with smart devices – nearly met the Qualcomm Tricorder XPrize’s audacious benchmarks for diagnosing 13 disease states. In the process, a Philadelphia area team started by siblings and a Taiwan-based team sponsored by HTC Corp. each took home millions of dollars as Tricorder XPrize winners after an April 12 awards ceremony. Read more 4. Novocure gains on additional Optune data Shares in Novocure are on the rise again after the company today cited additional data from a pivotal trial evaluating its Optune device with temozolomide chemotherapy as a treatment for newly-diagnosed glioblastoma. Novocure’s Optune mobile device delivers low-intensity, intermediate frequency, alternating electric fields, called “tumor treating fields” or TTFields, to inhibit cancer cell replication. Read more 3. Syneron-Candela levels poaching s...
Source: Mass Device - Category: Medical Equipment Authors: Tags: Blog Plus 5 Source Type: news